These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
880 related items for PubMed ID: 27723279
1. International Retrospective Chart Review of Treatment Patterns in Severe Familial Mediterranean Fever, Tumor Necrosis Factor Receptor-Associated Periodic Syndrome, and Mevalonate Kinase Deficiency/Hyperimmunoglobulinemia D Syndrome. Ozen S, Kuemmerle-Deschner JB, Cimaz R, Livneh A, Quartier P, Kone-Paut I, Zeft A, Spalding S, Gul A, Hentgen V, Savic S, Foeldvari I, Frenkel J, Cantarini L, Patel D, Weiss J, Marinsek N, Degun R, Lomax KG, Lachmann HJ. Arthritis Care Res (Hoboken); 2017 Apr; 69(4):578-586. PubMed ID: 27723279 [Abstract] [Full Text] [Related]
2. Reasons for canakinumab initiation among patients with periodic fever syndromes: a retrospective medical chart review from the United States. Hur P, Lomax KG, Ionescu-Ittu R, Manceur AM, Xie J, Cammarota J, Gautam R, Sanghera N, Kim N, Grom AA. Pediatr Rheumatol Online J; 2021 Sep 14; 19(1):143. PubMed ID: 34521444 [Abstract] [Full Text] [Related]
3. Canakinumab for the Treatment of Autoinflammatory Recurrent Fever Syndromes. De Benedetti F, Gattorno M, Anton J, Ben-Chetrit E, Frenkel J, Hoffman HM, Koné-Paut I, Lachmann HJ, Ozen S, Simon A, Zeft A, Calvo Penades I, Moutschen M, Quartier P, Kasapcopur O, Shcherbina A, Hofer M, Hashkes PJ, Van der Hilst J, Hara R, Bujan-Rivas S, Constantin T, Gul A, Livneh A, Brogan P, Cattalini M, Obici L, Lheritier K, Speziale A, Junge G. N Engl J Med; 2018 May 17; 378(20):1908-1919. PubMed ID: 29768139 [Abstract] [Full Text] [Related]
4. Monogenic Periodic Fever Syndromes: Treatment Options for the Pediatric Patient. Ozen S, Demir S. Paediatr Drugs; 2017 Aug 17; 19(4):303-311. PubMed ID: 28497352 [Abstract] [Full Text] [Related]
6. Pattern and diagnostic evaluation of systemic autoinflammatory diseases other than familial Mediterranean fever among Arab children: a multicenter study from the Pediatric Rheumatology Arab Group (PRAG). Al-Mayouf SM, Almutairi A, Albrawi S, Fathalla BM, Alzyoud R, AlEnazi A, Abu-Shukair M, Alwahadneh A, Alsonbul A, Zlenti M, Khawaja E, Abushhaiwia A, Khawaja K, AlMosawi Z, Madan W, Almuatiri M, Almuatiri N, for Pediatric Arab Rheumatology Group (PRAG). Rheumatol Int; 2020 Jan 17; 40(1):49-56. PubMed ID: 31741047 [Abstract] [Full Text] [Related]
10. Treatment of hereditary autoinflammatory diseases. Ter Haar NM, Frenkel J. Curr Opin Rheumatol; 2014 May 17; 26(3):252-8. PubMed ID: 24667287 [Abstract] [Full Text] [Related]
11. Other autoinflammatory disease genes in an FMF-prevalent population: a homozygous MVK mutation and a novel heterozygous TNFRSF1A mutation in two different Turkish families with clinical FMF. Karacan İ, Uğurlu S, Tolun A, Tahir Turanlı E, Ozdogan H. Clin Exp Rheumatol; 2017 May 17; 35 Suppl 108(6):75-81. PubMed ID: 29148404 [Abstract] [Full Text] [Related]
17. Real-world safety and effectiveness of canakinumab in patients with tumour necrosis factor receptor-associated periodic syndrome or hyperimmunoglobulinaemia D syndrome: Interim results from post-marketing surveillance in Japan. Hosono K, Matsumoto K, Shimbo M, Tsumiyama I, Kato C. Mod Rheumatol; 2023 Mar 02; 33(2):381-391. PubMed ID: 35575279 [Abstract] [Full Text] [Related]
19. Evidence-based provisional clinical classification criteria for autoinflammatory periodic fevers. Federici S, Sormani MP, Ozen S, Lachmann HJ, Amaryan G, Woo P, Koné-Paut I, Dewarrat N, Cantarini L, Insalaco A, Uziel Y, Rigante D, Quartier P, Demirkaya E, Herlin T, Meini A, Fabio G, Kallinich T, Martino S, Butbul AY, Olivieri A, Kuemmerle-Deschner J, Neven B, Simon A, Ozdogan H, Touitou I, Frenkel J, Hofer M, Martini A, Ruperto N, Gattorno M, Paediatric Rheumatology International Trials Organisation (PRINTO) and Eurofever Project. Ann Rheum Dis; 2015 May 02; 74(5):799-805. PubMed ID: 25637003 [Abstract] [Full Text] [Related]
20. The 2021 EULAR/American College of Rheumatology Points to Consider for Diagnosis, Management and Monitoring of the Interleukin-1 Mediated Autoinflammatory Diseases: Cryopyrin-Associated Periodic Syndromes, Tumour Necrosis Factor Receptor-Associated Periodic Syndrome, Mevalonate Kinase Deficiency, and Deficiency of the Interleukin-1 Receptor Antagonist. Romano M, Arici ZS, Piskin D, Alehashemi S, Aletaha D, Barron K, Benseler S, Berard RA, Broderick L, Dedeoglu F, Diebold M, Durrant K, Ferguson P, Foell D, Hausmann JS, Jones OY, Kastner D, Lachmann HJ, Laxer RM, Rivera D, Ruperto N, Simon A, Twilt M, Frenkel J, Hoffman HM, de Jesus AA, Kuemmerle-Deschner JB, Ozen S, Gattorno M, Goldbach-Mansky R, Demirkaya E. Arthritis Rheumatol; 2022 Jul 02; 74(7):1102-1121. PubMed ID: 35621220 [Abstract] [Full Text] [Related] Page: [Next] [New Search]